{"status": "ok", "totalResults": 289, "articles": [{"source": {"id": "the-guardian-au", "name": "The Guardian (AU)"}, "author": "Jamie Doward", "title": "Cost of lifesaving heroin withdrawal drug soars by 700%", "description": "Treatment agencies warn of extra drug-related deaths unless price hike is addressed A 700% spike in the price of a drug used to wean addicts off heroin has caused alarm among treatment agencies, which warn of a rise in drug-related deaths unless urgent action\u2026", "url": "https://www.theguardian.com/politics/2018/sep/29/heroin-withdrawal-generic-drug-price-hike", "urlToImage": "https://i.guim.co.uk/img/media/87252f8d32fd907df11fd163f38f16f4cb4e9156/0_249_5000_3000/master/5000.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&crop=faces%2Centropy&bm=normal&ba=bottom%2Cleft&blend64=aHR0cHM6Ly9hc3NldHMuZ3VpbS5jby51ay9pbWFnZXMvb3ZlcmxheXMvZjZlYzA2YWNlZGUwZWRmMDNiMDM3MmE1Y2VkZWJmZTIvdG8tZGVmYXVsdC5wbmc&s=3cdc1d2d388e4e241235b379d44e2b5a", "publishedAt": "2018-09-29T13:00:25Z", "content": "A 700% spike in the price of a drug used to wean addicts off heroin has caused alarm among treatment agencies, which warn of a rise in drug-related deaths unless urgent action is taken to make it more affordable. Buprenorphine is an alternative to methadone t\u2026 [+4049 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Pharma stks up; Sun Pharma, Lupin top gainers", "description": "The Nifty Pharma index was trading 1.68 per cent up at 10,163 at 10:35 am, with all components in the green zone.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/share-market-update-pharma-stocks-rise-up-to-4-aurobindo-pharma-sun-pharma-lupin-top-gainers/articleshow/65944686.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65944693,width-1070,height-580,imgsize-133450,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-25T05:03:02Z", "content": "NEW DELHI: Most pharma stocks were trading with gains during Tuesday's session even as broader market sentiment was wobbly. The Nifty Pharma index was trading 1.68 per cent up at 10,163 at 10:35 am, with all components in the green zone. Aurobindo Pharma (up \u2026 [+879 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ET Now", "title": "Mkt falling? Buy selectively in these 3 spaces: Deven Choksey", "description": "\u201cNot very sure of  a currency play in IT and pharma sectors.\u201d", "url": "https://economictimes.indiatimes.com/markets/expert-view/market-falling-you-could-buy-selectively-in-these-3-spaces-deven-choksey/articleshow/65944443.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65944446,width-1070,height-580,imgsize-399081,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-25T04:49:19Z", "content": "With oil price zooming, rupee could reach 75-76 level against dollar and that will cause a significant amount of stress, Deven R Choksey, MD, KR Choksey, tells ET Now. Insurance, corporate banks and auto &amp; auto ancillaries have corrected enough and can be\u2026 [+5264 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Buy Sun Pharma: Equity99", "description": "We are expecting strong performance in Q2 also and are recommending a buy in staggered manner for medium to long term, says Sumit Bilgaiyan of Equity99.", "url": "https://www.moneycontrol.com/news/business/markets/buy-sun-pharma-equity99-3021601.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/08/Sun-Pharma-770x433.jpg", "publishedAt": "2018-10-08T02:46:04Z", "content": "Sumit Bilgaiyan Equity99 Pharmaceutical stocks are little bit safe in this kind of market. Sun Pharma has reported better-than-expected performance in Q1FY19, led by healthy US sales (ex-Taro), strong growth in domestic business. Its sales and EBITDA grew by \u2026 [+870 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Stocks in the news: Strides Pharma, Tata Steel, ICICI Bank, Sun Pharma, KIOCL, RITES, Weizmann Forex", "description": "Stocks in the news: Strides Pharma, Tata Steel, ICICI Bank, Sun Pharma, KIOCL, RITES, Weizmann Forex", "url": "https://www.moneycontrol.com/news/business/stocks/stocks-in-the-news-strides-pharma-tata-steel-icici-bank-sun-pharma-kiocl-rites-weizmann-forex-2964261.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2017/03/stocks_BSE_Nifty_Sensex__bse_nifty-1_1280-770x433.jpg", "publishedAt": "2018-09-19T02:23:40Z", "content": "Here are the stocks that are in news today: SEBI lowers IPO listing timeline to T+3 from current T+6 SEBI approves new KYC norms for FPIs ICICI Bank : The bank in clarification note said it has not filed any application for settlement after certain media repo\u2026 [+5706 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "Lydia Ramsey", "title": "How a Groupon co-founder's experience with a lack of cancer data led him to start a company that's now worth $2 billion after just three years", "description": "Tempus, a cancer care data company, has grown like crazy to a $2 billion valuation. The three-year-old Chicago-based company pulls together data on cancer patients on its platform, including genetic data from tumors and clinical data about how well a patient \u2026", "url": "https://www.businessinsider.com/cancer-data-startup-tempus-now-worth-2-billion-2018-9", "urlToImage": "https://amp.businessinsider.com/images/560159229dd7cc11008bc1bd-1920-960.jpg", "publishedAt": "2018-09-27T18:37:42Z", "content": "Eric Lefkofsky, chief executive officer of biotechnology company Tempus, arrives for a morning session of the annual Allen &amp; Company Sun Valley Conference. Drew Angerer/Getty Images In 2015, the world was just starting to get outraged about drug pricing, \u2026 [+5844 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Almirall gets European Commission approval for psoriasis drug : Sun Pharma", "description": "In July 2016, Sun Pharma out-licensed Ilumetri (tildrakizumab) to Almirall, for the development and commercialisation of the product in Europe.", "url": "https://www.moneycontrol.com/news/business/almirall-gets-european-commission-approval-for-psoriasis-drug-sun-pharma-2963311.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/08/Sun-Pharma-770x433.jpg", "publishedAt": "2018-09-18T14:20:05Z", "content": "Sun Pharma said Spanish firm Almirall has received approval from the European Commission (EC) for Ilumetri, a drug used for treating psoriasis. In July 2016, Sun Pharma out-licensed Ilumetri (tildrakizumab) to Almirall, for the development and commercialisati\u2026 [+403 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Sun Pharma to pump in Rs 200 crore more in Assam plant", "description": "Assam Chief Minister Sarbananda Sonowal on Saturday inaugurated a new production line at Sun Pharma#39;s facility in Palashbari.", "url": "https://www.moneycontrol.com/news/business/sun-pharma-to-pump-in-rs-200-crore-more-in-assam-plant-3043301.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/08/Sun-Pharma-770x433.jpg", "publishedAt": "2018-10-13T12:45:05Z", "content": "The Assam government on Saturday said medicine firm Sun Pharma will invest an additional Rs 200 crore at its plant in the state to augment operations. Assam Chief Minister Sarbananda Sonowal on Saturday inaugurated a new production line at Sun Pharma's facili\u2026 [+1358 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Hold Sun Pharma; target of Rs 580: Centrum", "description": "Centrum recommended hold rating on Sun Pharma with a target price of Rs 580 in its research report dated September 17, 2018.", "url": "https://www.moneycontrol.com/news/business/stocks/hold-sun-pharma-target-of-rs-580-centrum-2969031.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2017/03/hold2-770x433.jpg", "publishedAt": "2018-09-20T10:33:47Z", "content": "Centrum's research report on Sun Pharma We maintain our Hold rating on Sun Pharma (SPIL) with TP of Rs580 (earlier Rs580) based on 26x March\u201920E EPS of Rs22.4. SPIL has developed a strong pipeline of specialty products for the US. It has received US FDA appro\u2026 [+1046 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Buy Sun Pharma; target of Rs 790: Motilal Oswal", "description": "Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 790 in its research report dated September 19, 2018.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-sun-pharma-target-of-rs-790-motilal-oswal-2-2968511.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2017/03/BUY_Sell_hold1-770x433.jpg", "publishedAt": "2018-09-20T11:26:59Z", "content": "Motilal Oswal's research report on Sun Pharma The USFDA conducted an inspection at SUNP's Mohali plant during 10-14 September 2018, and issued Form 483 with two observations. We believe SUNP will be able to address these observations with a strong response, a\u2026 [+1312 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Sun Pharma gains 2% on European Commission approval for Ilumetri", "description": "The roll out of Ilumetri in Europe will start in the next few weeks.", "url": "https://www.moneycontrol.com/news/business/markets/sun-pharma-gains-2-on-european-commission-approval-for-ilumetri-2964601.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/08/Sun-Pharma-770x433.jpg", "publishedAt": "2018-09-19T04:11:44Z", "content": "Shares of Sun Pharmaceutical Industries added more than 2 percent in the early trade on Wednesday after company received European Commission (EC) approval for Ilumetri. Almirall has received the European Commission (EC) approval for Ilumetri (tildrakizumab) f\u2026 [+795 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Over 85 stocks hit 52-week lows on NSE", "description": "Positive global cues and rupee's recovery against the US dollar gave a boost to sentiment at home.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/share-market-update-over-85-stocks-defy-bullish-market-mood-hit-52-week-lows-on-nse/articleshow/65897351.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65897373,width-1070,height-580,imgsize-72597,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-21T06:01:00Z", "content": "NEW DELHI: Over 85 stocks, including Yes Bank, Jet Airways (India), JK Tyre &amp; Industries and Rane Holdings, defied bullish mood of domestic market, hitting 52-week lows on NSE during Friday's session. Rolta India, Sagar Cements, AGC Networks, Bafna Pharma\u2026 [+1240 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Dr Reddy#39;s Labs, Strides Pharma, Divis Lab, Lupin, Aurobindo Pharma to get astrological support: Satish Gupta", "description": "Pharma stocks like Dr Reddy#39;s Labs, Stride Pharma, Divis Lab, Lupin and Aurobindo Pharma will get astrological support, says Satish Gupta of astrostocktips.", "url": "https://www.moneycontrol.com/news/business/markets/dr-reddys-labs-strides-pharma-divis-lab-lupin-aurobindo-pharma-to-get-astrological-support-satish-gupta-2972311.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2017/09/GettyImages-513084906-e1505902571592-770x433.jpg", "publishedAt": "2018-09-21T05:56:06Z", "content": "Satish Gupta astrostocktips.in Today\u2019s planetary position: Moon will be transiting in Capricorn. Jupiter and Venus in Libra. Lord Saturn in Sagittarius. Ketu and Mars in Capricorn. Lord Rahu in Cancer. Sun in Virgo, Mercury in Leo. Pluto in Sagittarius. Neptu\u2026 [+2678 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Strides Pharma, Divis Labs, Lupin, Natco Pharma, Aurobindo Pharma to get astrological support: Satish Gupta", "description": "Pharma stocks like Strides Pharma, Divis Labs, Lupin, Natco Pharma and Aurobindo Pharma will get astrological support, says Satish Gupta of astrostocktips.", "url": "https://www.moneycontrol.com/news/business/markets/strides-pharma-divis-labs-lupin-natco-pharma-aurobindo-pharma-to-get-astrological-support-satish-gupta-2987281.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/02/Budget-2018_Pharma_1280x720-770x433.jpg", "publishedAt": "2018-09-26T05:08:13Z", "content": "Satish Gupta astrostocktips.in Todays planetary position: Moon will be transiting in Pisces. Jupiter and Venus in Libra. Lord Saturn in Sagittarius. Ketu and Mars in Capricorn. Lord Rahu in Cancer. Sun and Mercury in Virgo, Pluto in Sagittarius. Neptune in Aq\u2026 [+2666 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Dr Reddy#39;s Labs, Aurobindo Pharma, Ajanta Pharma, Wockhardt to get astrological support: Satish Gupta", "description": "Pharma stocks like Dr Reddy#39;s Labs, Aurobindo Pharma, Ajanta Pharma, Wockhardt and Strides Pharma will get astrological support, says Satish Gupta of astrostocktips.", "url": "https://www.moneycontrol.com/news/business/markets/dr-reddys-labs-aurobindo-pharma-ajanta-pharma-wockhardt-to-get-astrological-support-satish-gupta-3025471.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/06/USFDAFDAPILLSDRUGSTABLETSPHARMA-770x433.jpg", "publishedAt": "2018-10-09T05:07:46Z", "content": "Satish Gupta astrostocktips.in Weekly planetary position: Moon will be transiting in Virgo. Jupiter, Venus and Mercury in Libra. Lord Saturn in Sagittarius. Ketu and Mars in Capricorn. Lord Rahu in Cancer. Sun in Virgo, Pluto in Sagittarius. Neptune in Aquari\u2026 [+2964 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Over 90 stocks touch 52-week lows on BSE", "description": "The BSE Sensex was down 141 points at 34,592 around 11:15 am.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/share-market-update-over-80-stocks-touch-52-week-lows-on-bse/articleshow/66212582.cms", "urlToImage": "https://img.etimg.com/thumb/msid-66212604,width-1070,height-580,imgsize-190046,overlay-etmarkets/photo.jpg", "publishedAt": "2018-10-15T05:22:35Z", "content": "NEW DELHI: Over 90 stocks, including Ashapura Intimates Fashion, Amrit Corp, Anjani Portland Cement, Arihant Foundations &amp; Housing and Bhatia Communications &amp; Retail (India), hit 52-week lows on BSE in Monday's session. Kiran Vyapar, Raw Edge Industri\u2026 [+1025 chars]"}, {"source": {"id": null, "name": "Indianexpress.com"}, "author": "PTI", "title": "Sensex falls over 100 pts on foreign fund outflow, rising oil prices", "description": "The 30-share index fell 124.63 points, or 0.34 per cent, to 36,180.39, after touching a high of 36,454.03 at the outset. The rupee too depreciated by 33 paise to 72.96 against the US dollar in early trade at the interbank forex market.", "url": "https://indianexpress.com/article/business/market/sensex-falls-over-100-pts-on-foreign-fund-outflow-rising-oil-prices-5373042/", "urlToImage": "https://images.indianexpress.com/2018/01/sensex.jpg?w=759", "publishedAt": "2018-09-25T05:04:47Z", "content": "By: PTI | Mumbai | Updated: September 25, 2018 10:35:39 am The NSE Nifty fell by 33.40 points, or 0.30 per cent, to 10,934. Benchmark indices turned volatile after opening higher Tuesday on foreign fund outflows, surging global crude oil prices, weak rupee an\u2026 [+1711 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Ambuja Cement falls after SC stays CCI penalty", "description": "The NSE Nifty50 index was trading 138 points down at 10,461 around 11:30 am.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/stock-market-update-ultratech-cement-acc-ambuja-cements-fall-after-sc-stays-cci-penalty/articleshow/66082163.cms", "urlToImage": "https://img.etimg.com/thumb/msid-66082178,width-1070,height-580,imgsize-144544,overlay-etmarkets/photo.jpg", "publishedAt": "2018-10-05T06:01:50Z", "content": "NEW DELHI: Shares of select cement firms, including Ultratech Cement, ACC and Ambuja Cements, came under pressure in Friday's session after the Supreme Court stayed the Rs 6,300 crore penalty imposed by the fair trade regulator CCI for alleged cartelisation. \u2026 [+1137 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "BUY, SELL, HOLD ideas from D-Street experts", "description": "ITC is a 'Buy' call with a target price of Rs 285 and a stop loss of Rs 270.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/top-intraday-trading-ideas-for-afternoon-trade-for-friday-12-october-2018/articleshow/66175655.cms", "urlToImage": "https://img.etimg.com/thumb/msid-66175654,width-1070,height-580,imgsize-351913,overlay-etmarkets/photo.jpg", "publishedAt": "2018-10-12T06:26:33Z", "content": "NEW DELHI: Equity benchmarks Sensex and Nifty50 were in positive terrain around 11:55 am on Friday on buying in most sectors. The rise in the market was underpinned by easing crude oil prices, falling dollar and bond yields in the US and positive Asian cues. \u2026 [+991 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Over 120 stocks hit 52-week lows on NSE", "description": "However, nearly 30 stocks hit 52-week highs on BSE.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/stock-market-update-over-120-stocks-defy-positive-market-mood-hit-52-week-lows/articleshow/66175413.cms", "urlToImage": "https://img.etimg.com/thumb/msid-66175462,width-1070,height-580,imgsize-224061,overlay-etmarkets/photo.jpg", "publishedAt": "2018-10-12T06:00:51Z", "content": "NEW DELHI: Over 120 stocks tested 52-week lows on the BSE today in an otherwise buoyant market in which, Sensex surged over 600 points and the Nifty hit off 10,450. Among the stocks that touched their 52-week lows were 8K Miles Software Services, AGC Networks\u2026 [+1138 chars]"}]}